SINGAPORE: Singapore is not a low-cost manufacturing base, but good infrastructure, respect for intellectual property, access to talent, and a government with a vision are what makes it the go-to destination for US pharma giant Pfizer.
“There are no short-term investments in the world of pharmaceuticals,” said Mike McDermott, chief global supply officer and executive vice-president of Pfizer.
